PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22564758-2	2012	This study investigates the effects of naloxonazine, a specific mu-opioid receptor antagonist, on the locomotor behavioral response and phosphorylation pattern of dopamine and cAMP-regulated phosphoprotein of Mr32 (DARPP-32) in striatal dopaminergic transmissions induced by acute administration of METH to mice.	naloxonazine	39-51	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	163-213	
22564758-2	2012	This study investigates the effects of naloxonazine, a specific mu-opioid receptor antagonist, on the locomotor behavioral response and phosphorylation pattern of dopamine and cAMP-regulated phosphoprotein of Mr32 (DARPP-32) in striatal dopaminergic transmissions induced by acute administration of METH to mice.	naloxonazine	39-51	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	215-223	
22564758-7	2012	Results show that pretreatment with naloxonazine significantly attenuated the acute METH-induced increase in locomotor activity and phosphor-Thr75 DARPP-32 levels.	naloxonazine	36-48	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	147-155